The global direct-fed microbials market is estimated to be valued at USD 934.5 Million in 2016 and projected to reach USD 1,399.6 Million by 2022, at a CAGR of 6.96% from 2016. Direct-fed microbial-based feed plays a vital role in providing health and medicinal benefits to animals such as preclusion and cure of diseases in addition to the basic nutritional components found in feedstuff. A decline in the usage of antibiotic growth promoters across the globe is driving the sales of direct-fed microbials. In 2006, the European Union was the first to impose a ban on the use of antibiotics for promoting growth in animals. This has led Europe to become the fastest-growing market for direct-fed microbials, which are widely used as an alternative. The increasing instances of bans on antibiotics in other parts of the world have also further fueled market growth, with North America now being the largest market for direct-fed microbials.

Significant growth expected in the lactic acid bacteria segment

Lactic acid bacteria are gaining high popularity in the direct-fed microbials (DFM) market across the world, the demand for lactic acid bacteria used in feed for animal health and nutrition have been contributing to the growth in the market. Lactic acid bacteria are more convenient to use, owing to their ease in application. They are the most widely used direct-fed microbials and hence, the lactic acid bacteria segment is projected to be the fastest-growing for the next six years.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91112718

The poultry segment is projected to be the fastest-growing during the forecast period.

The role of direct-fed microbials in poultry includes altering the metabolism by enhancing digestive enzyme activity, maintaining normal intestinal microflora, and reducing bacterial enzyme activity and ammonia production. They improve feed intake and digestion, neutralize enterotoxins, and stimulate the immune system. Such benefits are driving the demand for direct-microbials in the poultry sector.

Significant growth in demand for direct-fed microbials in animal feed observed in the North American region

Due to recent outbreaks of diseases such as avian influenza or avian flu, and foot & mouth disease, the meat market in North America, especially in the U.S., has become cautious about food safety and quality. The U.S. government took initiatives such as the complete ban, in 2009, on the use of feed antibiotics as growth promoters, and campaigns for increasing awareness about product efficiency and its proper usage. With the ban on the use of feed antibiotics as growth promoters, the direct-fed microbials (DFM) market in North America has grown.

This report includes a study of marketing and development strategies, along with the product portfolio of leading companies. It includes the profiles of leading companies such as Archer Daniels Midland Company (U.S.), E. I. du Pont de Nemours and Company (U.S.), Koninklijke DSM N. V. (Netherlands), Novozymes (Denmark), Chr. Hansen A/S (Denmark), Kemin Industries (U.S.), BIOMIN Holding GmbH (Austria), Lallemand Inc. (Canada), Novus International, Inc. (U.S.), and Bio-vet (U.S.).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=91112718

Target Audience

The stakeholders for the report are as follows:

• Direct-fed microbial manufacturers
• Feed manufacturers
• Animal pharmaceutical companies
• Direct-fed microbial raw material suppliers
• Direct-fed microbial product exporters & importers
• Educational institutions
• Regulatory authorities
• Consulting firms